I’m delighted to warmly welcome you to the Griffith Institute for Drug Discovery (GRIDD), where our purpose is creating knowledge that transforms lives.
Recently, we made our purpose even clearer by giving ourselves this new name. As the former Eskitis Institute, we laid a strong foundation and now it’s time for the next leap forward as GRIDD to fast-track the search for new treatments targeting the world’s most devastating diseases.
You can find information on this website about our innovative progress towards new solutions for cancer, Parkinson’s disease, infectious diseases, drug resistance and spinal cord injury repair, as well as our unique resources and exceptional people.
We achieve our results through a combination of outstanding researchers, an extensive global partnership network and our unique resources, Compounds Australia and Nature Bank.
I’m especially proud that our Professor Emeritus Alan Mackay-Sim was named 2017 Australian of the Year in recognition of his groundbreaking work in stem cell and spinal cord injury repair.
Our inclusive and innovative culture; our values of excellence, integrity, respect, collegiality; and our connections with community, clinicians, government, industry, and other academics all contribute to our ongoing success.
I’m enormously grateful for the support we receive through our industry partnerships, academic and clinical collaborations, grants and donations. To conquer complex human diseases we need to work together across sectors, and that means we continue to need your support.
Alongside our research, our outstanding leaders also train and inspire the next generation of scientists.
Please join with us, in whichever way you can, to help us conquer human diseases.
Thank you so much for your support.
Professor Jennifer Martin, FAA
BPharm MPharm DPhil (Oxon)